Eileen Barr, an obesity physician in East Setauket
The 64-week study enrolled 307 adults with obesity or overweight plus at least one weight-related comorbidity
Louis Lipo , we recognize the revolutionary impact of GLP-1-based drugs on obesity treatment and are dedicated to providing cutting-edge solutions for those seeking help with weight management
While these opportunities exist, brands must proceed in an ethical manner: remember that this is a medical nutrition product, rather than a mass market offering, Hughes said
It is often well-tolerated in moderate doses but may have a mild laxative effect, which could be problematic for GLP-1 users already experiencing diarrhea or gastrointestinal upset
Third, dosing accuracy varies between compounding pharmacies